Industry N Nature Biomedical Engineering
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Industry N Nature Biomedical Engineering
Industry
Nature Biotechnology
Industry
Nature Biotechnology
Industry N Nature Medicine
Software N Nature Medicine
Industry N Nature Medicine
Industry N Nature Biomedical Engineering
Industry
BioCentury
BIOCENTURY | DEALSCSL BUYS INTO ALENTIS’ LEAD AUTOIMMUNE PROGRAM FOR $355M: DEALS REPORTPlus: Genentech brings in Alector’s brain-shuttling ERT; Shionogi/IntraBio; Novartis/Abogen; Sanofi/Regeneron; Novo/Hengrui; and more
Software W Weekly Tech+Bio
ALSO: Enveda, Anew Labs and Varda raise over $850M between them; Genentech signs a $1.5B collaboration with Earendil; Neuralink pretrains on 50,000 hours of brain data and reports a BCI record, and mo
Software A Arcadia Science
Comparing the geometry of RNA, protein, and growth measurements in natural yeast strains, we find that each biological layer reorganizes the shape of phenotypic variation in a distinct way. Phenotypic geometry is a property that must be measured rather than assumed.
Industry
BioCentury
BIOCENTURY | DEALSBUILDING AGAIN IN RARE DISEASES, SHIONOGI PAYS $2B FOR INTRABIOAcquisition would give Japanese pharma a therapy approved for two disorders, including one first-in-disease indication
Research
GEN
Researchers developed a method for testing how closely lab-grown blastoid models resemble real human embryos, finding that while some models perform well, none fully captures the complexity of early human development. The post A Method for Assessing Lab-Grown Stem Cell-Derived Em…
Clinical
BioCentury
BIOCENTURY | PRODUCT DEVELOPMENTVAXCYTE’S PHASE III DATA STRENGTHEN CASE FOR BROADER PNEUMOCOCCAL COVERAGEBioCentury’s Clinical Report, Sept. 29 – Oct. 5
Industry
Inside Precision Medicine
Even when calories, macronutrients and other nutritional characteristics were closely matched, ultraprocessed foods produced a different insulin and fuel-use response. The study also linked these metabolic differences to altered brain responses to food cues. The post Ultra-Proces…
Industry
GEN
Researchers have uncovered how phage proteases activate CBASS antiphage immunity, revealing a novel bacterial virus-sensing mechanism that could inform development of more effective phage therapies. The post Phage Proteases Trigger a Conserved Bacterial Antiviral Defense Pathway…
Industry
Inside Precision Medicine
Increasing levels of chaperone-mediated autophagy, a process reduced by aging, could improve health by reducing inflammation and the build up of fibrotic tissue in some diseases. The post Reversing a Cellular Aging Process Could Help Treat Fibrotic Disease appeared first on Insid…
Funding
MedCity News
Shionogi’s IntraBio acquisition brings Aqneursa, a drug approved for treating two rare neurological disorders and the potential to expand to additional indications, both rare and common. It’s Shionogi’s second big rare disease move this year, following the acquisition of global r…
Industry
GEN
A study in human monocyte-derived microglia and human brain tissue slices suggests that inflammatory brain conditions, including traumatic brain injury and neurodegenerative diseases such as Alzheimer's disease, could be treated using an existing drug candidate targeting P2X7R. T…
Manufacturing B BioPharm International
Survodutide advances metabolic disease treatment, while biosimilar capacity expands, FDA delays hemophilia review, and lupus data support next steps.
Software
Fierce Pharma
Why AI’s Biggest Value in Pharma Is Confidence scox Mon, 10/05/2026 - 16:27
Research
GEN
Stuart Orkin, MD, and his former trainees Vijay Sankaran, MD, PhD, and Daniel Bauer, PhD, were joined by Swee-Lay Thein, MD, PhD, and John Tisdale, MD, both at the NIH. Their contributions helped to identify BCL11A as a major regulator of the fetal-to-adult hemoglobin switch. The…
Industry A Applied Clinical Trials
Mixed FSP and FSO models are gaining ground as sponsors seek agility and resource flexibility, but the oversight infrastructure, audit trails, and accountability structures needed to run them well and survive regulatory inspection are consistently lagging behind the model itself.
Industry
Fierce Biotech
"The Next Signal": Where Commercial Pharma Data Is Headed dwunderlin Mon, 10/05/2026 - 14:28 Thu, 10/22/2026 - 14:00 Resource Type Webinar Amy Crowe Stephan Dunning, MBA, MS Commercial teams see patient activity after the fact in healthcare claims. Before a patient is seen, their…
Industry
Fierce Pharma
"The Next Signal": Where Commercial Pharma Data Is Headed dwunderlin Mon, 10/05/2026 - 14:28 Thu, 10/22/2026 - 14:00 Resource Type Webinar Amy Crowe Stephan Dunning, MBA, MS Commercial teams see patient activity after the fact in healthcare claims. Before a patient is seen, their…
Industry P pharmaphorum
Vaxcyte's pneumococcal jab exceeds expectations Phil.Taylor Mon, 05/10/2026 - 18:21
Industry P Pharmaceutical Executive
Jewel Jones warns that pharma catches patient disengagement too late, CSL and Alentis Therapeutics join Jiangsu Nhwa and Somnivera in a day of new licensing deals, and Corxel's Bo Liang calls GLP-1's leap to bariatric-surgery-level efficacy the biggest surprise in obesity medicin…
Clinical B BioPharm International
Litifilimab extended skin responses through 52 weeks in phase 2 AMETHYST data in cutaneous lupus erythematosus, with phase 3 results expected in 2027.
Manufacturing B BioProcess International
The first module is scheduled to open in 2031 with the second to follow in 2034.
Manufacturing P Pharmaceutical Commerce
At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains.
Regulatory B BioPharm International
Manufacturing remediation, not efficacy or safety data, is delaying US approval of Novo's h+emophilia A therapy denecimig.
Regulatory B BioPharm International
Doubled drug substance capacity at Alvotech's Reykjavik, Iceland, site aims to secure steady US supply of the Humira biosimilar Simlandi.
Industry P pharmaphorum
Lilly's BTK drug Jaypirca joins first-line options in US Phil.Taylor Mon, 05/10/2026 - 16:11
Regulatory A Applied Clinical Trials
A new request for information asks for comments on dose selection, safety monitoring, eligibility criteria, and oversight approaches to support the responsible development of ibogaine drug products.
Manufacturing B BioProcess International
The IND pilot is part of the HHS's ongoing mission to onshore clinical trials.
Funding
BioPharma Dive
The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the company a marketed treatment for two inherited conditions.
Industry
GEN
HORIBA recently unveiled an Applications Solutions Plaza (ASP) at its Piscataway, New Jersey facility. The ASP allows customers to bring samples for testing or receive on-site demonstrations using modular, laboratory setups configured around specific pain points. The post HORIBA…
Research
Drug Discovery and Development
The field of digital pathology went from a specialist interest to a practical necessity during the pandemic, when many pathologists couldn’t get to the microscope. Digitizing slides let them keep working remotely. Since then, researchers have developed ways to extract more inform…
Industry
C&EN Pharmaceuticals
Researchers use cell-surface carbohydrate chemistry to guide regenerative cells straight to bone marrow
Funding
MedTech Dive
Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture and distribute time-sensitive drugs used in PET imaging.
Industry
BioSpace
Adecto Pharmaceuticals has ceased operations, while Aviceda Therapeutics is in the process of winding down.